Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will commission research to establish whether covid-19 vaccinations work effectively for people who have received kidney transplants.

As part of the COVID-19 Immunity National Core Study, UK Research and Innovation (UKRI) is providing initial funding of £1.8 million for 12 months towards the OCTAVE study. The OCTAVE study will examine the effectiveness of COVID-19 vaccines in clinically at-risk groups, including patients with certain immunosuppressed conditions, including renal transplant patients.

Public Health England has been monitoring the effectiveness of vaccinations in clinical risk groups including those with immunosuppression.

From the evaluation of the vaccine programme, the data shows that completion of the two dose schedule correlates well with protection from both disease and severe outcomes.